Apple unveils a new Apple Watch generation with enhanced health tracking at the September 2026 event (9 September, Apple Park, confirmed by Apple press release or apple.com)
Hit
✦ AI-generated prediction
Published on 30. August 2026
·
Predicted for 9. September 2026
·
Based on: Historical Cycle
Apple's September 2026 event is officially confirmed for 9 September under the theme 'Surprise and Shine' at Apple Park (MacRumors, 26.08.2026). Apple has introduced a new Apple Watch generation at every September event since 2015 — an exception would be historically unique. Alongside the iPhone 18 Pro and foldable iPhone Ultra (A20 Pro chip), the new Apple Watch (Series 12 or new naming) with the long-awaited blood pressure monitoring health upgrade has been planned since 2025 (per MacRumors/Digital Trends). Probability is very high — Apple never closes its fall lineup without Apple Watch.
Data basis for this prediction
- MacRumors: Apple September Event 2026 bestätigt, 9. Sept., 'Surprise and Shine' (26.08.2026)
- Digital Trends: iPhone 18 Pro/Ultra Event Details inkl. A20-Pro-Chip (Aug 2026)
- Apple Watch Tradition: neue Generation bei jedem September-Event seit 2015 (apple.com, historisch)
Verdict: Hit
Die Vorhersage ist eingetreten. Apple hielt das September-Event am 9. September 2026 unter dem Motto 'Surprise and Shine' im Apple Park ab und stellte die Apple Watch Series 12 mit dem neuen S11-Chip und einem deutlich erweiterten Health-Tracking-System vor: Herzfrequenzmessung alle 5 Sekunden (60x häufiger als zuvor), neue 'Readiness'-Funktion, HRV-Messung alle 5 Minuten und eine neue 'Health Age'-Funktion. Dies wurde u.a. auf MacRumors (macrumors.com/2026/09/09/apple-watch-series-12-announced-all-day-hr-sensor/) und 9to5Mac (9to5mac.com/2026/09/09/apple-watch-series-12-and-ultra-4-unveiled-with-upgraded-health-tracking-system/) bestätigt. Einschränkung: Das in der Vorhersagebegründung erwähnte Blutdruck-Feature war bereits 2025 mit der Apple Watch Series 11 eingeführt worden – die Series 12 brachte andere, neue Health-Upgrades. Der Kern der Vorhersage (neue Apple Watch-Generation mit erweitertem Health-Tracking am 9. September 2026) ist jedoch vollständig bestätigt.
💻 Technology
✦ AI
PLTR closed at $175.40 on November 4, 2026 (after-hours: $170.88, -2.58%; intraday high: $176.54; 52-week high: $212.94). Palantir clearly beat Q3-FY2026 EPS consensus: total revenue $2.313B, US Commercial revenue +148% YoY to $984M. The $185 threshold is +5.5% above the closing price or +8.3% above after-hours levels. Typical post-earnings 'sell the news' may weigh short-term, but the 52-week high of $212.94 confirms the level is reachable. NVIDIA earnings on November 18, 2026 could serve as a sector-wide catalyst. No direct Polymarket equivalent; own estimate: ~42%.
💻 Technology
✦ AI
CBRS trades at $109.18 (October 30, 2026) — already 61% below its all-time high of $279.72. The final and largest lockup expiration is scheduled for November 10, 2026: approximately 19.4 million shares are unlocked (of three tranches of 19.4M each). Prior lockup tranches have consistently weighed on the stock. Insiders have sold ~$394.6M in shares since the May 2026 IPO — zero insider purchases. A Culper Research short-seller report has triggered multiple investigations. A close below $100 requires a ~8.4% decline — plausible given the expected supply pressure on expiration day.
💻 Technology
✦ AI
ARM Holdings reports Q2 FY2027 (July–September 2026) on November 4 after market close. EPS consensus: $0.47; revenue consensus ~$1.38B (Theta Research, Oct 29). ARM is the dominant CPU IP licensor for AI servers (Neoverse), smartphones (Apple A-series, Qualcomm), and edge devices — all three segments scaling strongly in 2026. ARM has beaten EPS consensus in each of the last four quarters, driven by AI infrastructure capex. No direct Polymarket contract; analogue: S&P 500 Q3 2026 beat rate ~71%. Key risks: export control escalation (UK/US vs. China), hyperscaler capex delays, or HBM4 demand plateau.